Skip to main content
. 2020 Apr 8;10:6063. doi: 10.1038/s41598-020-62979-9

Table 4.

Clinical outcomes of hypothermic oxygenated perfusion and control organs.

Kidney HOPE (N = 10) Control
(N = 30)
Odds ratio/Effect size
(CI interval)
p value
PNF, n (%) 0 (0%) 1 (3.3%) 0.9667 OR (0.3506–2.6656) 0.9478
DGF, n (%) 2 (20%) 12 (40%) 0.7500 OR (0.2501–2.2489) 0.6076
Creatinine at 5 day post-transplant, media (SD) 3.5 ± 2 4.1 ± 2.6 − 0.24 ES (−0.96 to 0.48) 0.4572
eGFR on dimission day (mL/min/1.73 m²), media (SD) 52.4 ± 25.01 44.43 ± 21.4 − 0.35 ES (−0.37 to 1.07) 0.3762
Hospital stay (days), median (range) 17 (12–30) 24 (11–60) − 0.49 ES (−1.22 to 0.23) 0.0924
1-year graft survival, n (%) 10 (100%) 28 (93.3%) 0.9333 OR (0.3377–2.5796) 0.8936
1-year recipient survival, n (%) 10 (100%) 29 (96.6%) 0.9667 OR (0.3506–2.6656) 0.9478
Liver HOPE (N = 10)

Control

(N = 30)

Odds ratio/Effect size

(CI interval)

p value
PNF, n (%) 0 (0%) 2 (6.6%) 0.9633 OR (0.3377–2.5797) 0.8942
EAD, n (%) 0 (0%) 7 (23.3%) 0.7667 OR (0.2734–2.1501) 0.6135
Peak AST within 7 days (U/L), median (range) 344.5 (166–1132) 637 (124–2100) −0.82 EF (−1.55 to −0.08) 0.0060*
Peak ALT within 7 days (U/L), median (range) 330 (122–1350) 601 (114–1837) −0.52 EF (−1.24 to 0.20) 0.1438
Bilirubin on 7 day (mg/dL), media (SD) 3.14 ± 1.54 3.62 ± 3.22 −0.16 EF (−0.88 to 0.55) 0.5386
INR on 7 day, median (range) 1.17 (1.08–1.46) 1.24 (1.02–1.64) −0.60 EF (−1.32 to 0.13) 0.0434*
Hospital stay (days), median (range) 11.5 (7–29) 12.5 (7–109) −0.28 EF (−1.00 to 0.44 0.2350
1-year graft survival, n (%) 10 (100%) 27 (90%) 0.9000 OR (0.3248–2.4937) 0.8394
1-year recipient survival, n (%) 10 (100%) 27 (90%) 0.9000 OR (0.3248–2.4937) 0.8394

eGFR, Estimated Glomerular Filtration Rate; INR, International normalized ratio; PNF = primary non function; DGF = delay graft function; EAD = early allograft dysfunction; AST = aspartate transaminase; ALT = alanine transaminase.